PL397028A1 - Method for digitally-performed analytical and diagnostic indications - Google Patents
Method for digitally-performed analytical and diagnostic indicationsInfo
- Publication number
- PL397028A1 PL397028A1 PL397028A PL39702811A PL397028A1 PL 397028 A1 PL397028 A1 PL 397028A1 PL 397028 A PL397028 A PL 397028A PL 39702811 A PL39702811 A PL 39702811A PL 397028 A1 PL397028 A1 PL 397028A1
- Authority
- PL
- Poland
- Prior art keywords
- sub
- volume
- volumes
- sample
- values
- Prior art date
Links
Landscapes
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
Przedmiotem wynalazku jest sposób wyznaczania stezenia czasteczek w próbce, obejmujacy nastepujace kroki: a) podzial próbki na N rozdzielnych pod-objetosci, kazdej o objetosci vi, gdzie i jest indeksem pod-objetosci, przy czym albo próbke dzieli sie na pod-objetosci w sposób deterministyczny, to jest taki, w którym objetosci vi zadane sa przez ciag wartosci funkcji analitycznej f(i) lub przez predefiniowany zbiór wartosci, albo próbke dzieli sie na pod-objetosci w sposób losowy, to jest taki, by rozklad objetosci pod-objetosci byl zgodny z rozkladem prawdopodobienstwa P(v), to znaczy liczba pod-objetosci o objetosci vi w przedziale (v, v+?v) zadana jest wzorem: N?vv+?vP(v)dv; b) przeprowadzenie w kazdej tak uzyskanej pod-objetosci procesu wzmocnienia obecnosci co najmniej jednej wspomnianej czasteczki do mierzalnego sygnalu; c) pomiar wspomnianego sygnalu w kazdej pod-objetosci i przypisanie tej pod-objetosci parametru ki, przy czym parametr ki, przyjmuje wartosc 1, jezeli wynik wspomnianego pomiaru wskazuje na to, ze w danej pod-objetosci znajduje sie co najmniej jedna wspomniana czasteczka oraz 0 w przeciwnym wypadku, zas i jest numerem pod-objetosci; d) obliczenie sumy K = ?ki • wi(vi), gdzie i jest numerem pod-objetosci a suma przebiega po wszystkich pod-objetosciach na które zostala podzielona próbka i=1..N, zas wi(vi) jest waga, która moze zalezec od objetosci pod-objetosci; e) wyznaczenie estymaty E(C) stezenia wspomnianych czasteczek w próbce na podstawie wartosci K, N i {vi} lub P(v) za pomoca znanego algorytmu statystycznego opartego o formalizm Bayesa, charakteryzujacy sie tym, ze podzial próbki, o którym mowa w kroku a) obejmuje co najmniej dwie pod-objetosci o róznych objetosciach.The invention relates to a method for determining the concentration of particles in a sample, comprising the following steps: a) dividing the sample into N separate sub-volumes, each with the volume vi, where i is the index of the sub-volume, whereby either the sample is divided into sub-volumes in the manner deterministic, that is, one in which the volumes vi are given by the sequence of the values of the analytic function f (i) or by a predefined set of values, or the sample is divided into sub-volumes at random, i.e. consistent with the probability distribution P (v), that is, the number of sub-volumes with the volume vi in the interval (v, v + v) is given by the formula: N vv + vP (v) dv; b) performing in each sub-volume thus obtained a process of amplification of the presence of at least one said molecule for the measurable signal; c) measuring said signal in each sub-volume and assigning this sub-volume to the parameter ki, the parameter ki, being 1 if the result of said measurement indicates that there is at least one said molecule in a given sub-volume, and 0 otherwise, and i is the sub-volume number; d) calculation of the sum K =? ki • wi (vi), where i is the number of the sub-volume and the sum runs over all sub-volumes into which the sample was divided i = 1..N, while wi (vi) is the weight which may depend on the volume of the sub-volume; e) determination of the estimate E (C) of the concentration of the said molecules in the sample on the basis of the values of K, N and {vi} or P (v) using a well-known statistical algorithm based on the Bayesian formalism, characterized by the fact that the partition of the sample referred to in of step a) includes at least two sub-volumes with different volumes.
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL397028A PL397028A1 (en) | 2011-11-17 | 2011-11-17 | Method for digitally-performed analytical and diagnostic indications |
KR1020147016582A KR101839180B1 (en) | 2011-11-17 | 2012-11-19 | Method for performing quantitation assays |
US14/344,046 US20140278143A1 (en) | 2011-11-17 | 2012-11-19 | Method for performing quantitation assays |
EP12805938.3A EP2780470B1 (en) | 2011-11-17 | 2012-11-19 | Method for performing quantitation assays |
EA201490999A EA030186B9 (en) | 2011-11-17 | 2012-11-19 | Method for performing quantitation assays |
PL12805938T PL2780470T3 (en) | 2011-11-17 | 2012-11-19 | Method for performing quantitation assays |
PCT/EP2012/004792 WO2013072069A1 (en) | 2011-11-17 | 2012-11-19 | Method for performing quantitation assays |
JP2014541568A JP6055838B2 (en) | 2011-11-17 | 2012-11-19 | Methods for performing quantitative assays |
BR112014011818A BR112014011818A2 (en) | 2011-11-17 | 2012-11-19 | method for performing quantitation tests |
CN201280056869.7A CN104053784B (en) | 2011-11-17 | 2012-11-19 | Method For Performing Quantitation Assays |
HK15102763.4A HK1202311A1 (en) | 2011-11-17 | 2015-03-17 | Method for performing quantitation assays |
US15/658,073 US20170322136A1 (en) | 2011-11-17 | 2017-07-24 | Method for performing quantitation assays |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL397028A PL397028A1 (en) | 2011-11-17 | 2011-11-17 | Method for digitally-performed analytical and diagnostic indications |
Publications (1)
Publication Number | Publication Date |
---|---|
PL397028A1 true PL397028A1 (en) | 2013-05-27 |
Family
ID=48522704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL397028A PL397028A1 (en) | 2011-11-17 | 2011-11-17 | Method for digitally-performed analytical and diagnostic indications |
Country Status (1)
Country | Link |
---|---|
PL (1) | PL397028A1 (en) |
-
2011
- 2011-11-17 PL PL397028A patent/PL397028A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20191300T1 (en) | Size-based analysis of fetal dna fraction in maternal plasma | |
CN109239360B (en) | Reaction curve abnormity detection method and device | |
Normanno et al. | Prognostic value of circulating tumor cells’ reduction in patients with extensive small-cell lung cancer | |
CY1121741T1 (en) | USE OF EXTRACELLULAR DNA FRAGMENT SIZE TO DETERMINE COPY NUMBER VARIATION | |
McWalter et al. | Relating recent infection prevalence to incidence with a sub-population of assay non-progressors | |
JP2018509934A5 (en) | ||
AU2018260845A1 (en) | Evaluation and treatment of bradykinin-mediated disorders | |
EA030186B9 (en) | Method for performing quantitation assays | |
EP4279612A3 (en) | Analysis of fragmentation patterns of cell-free dna | |
RU2014134175A (en) | METHOD AND SYSTEM FOR IDENTIFICATION OF VARIATION OF THE NUMBER OF COPIES IN THE GENOME | |
JP2014002170A5 (en) | ||
BRPI0814202A2 (en) | METHODS AND SYSTEMS FOR DETERMINING PRODUCT CONCENTRATION ANALYSIS IN A FLUID SAMPLE AND COMPUTER READY | |
IN2014CN01970A (en) | ||
EP2081132A3 (en) | Novelty detection | |
MX2016005825A (en) | Methods and systems of evaluating a risk of lung cancer. | |
BR112014029679A2 (en) | method for performing in situ calibration electrophoresis | |
JP2017512996A5 (en) | ||
WO2015091575A3 (en) | Different levels in blood cell samples of emt-markers for the diagnosis of cancer, in particular of colorectal (crc) and pancreatic (pc) cancer | |
CN102866256B (en) | Detection method and detection reagent for hypersensitive C reactive protein | |
JP2018518725A5 (en) | ||
GB201206323D0 (en) | Methods and arrays for use in the same | |
JP5719433B2 (en) | Method, computer program and system for analyzing mass spectra | |
PL397028A1 (en) | Method for digitally-performed analytical and diagnostic indications | |
PL397027A1 (en) | Method for digitally-performed analytical and diagnostic indications | |
PL406989A1 (en) | Profile of micro RNA in blood as the test for detecting lung cancer |